-
Results of fits of optimal excess relative risk model (2) (maximum likelihood...
aUnless otherwise stated all p-values refer to improvement in fit of model immediately above indicated one in the Table.bp-value for improvement in fit over null model (without... -
Peptides used in this study.
NP and M2 peptides used in this study for analysis of immune responses. Amino acids in the challenge virus sequence which differ from the A/PR/8/34 sequence are underlined.... -
Bivariate correlations.
Spearman’s rank and †Kendall’s tau b correlation tests. Data used in the correlation analysis were collected at the time of prostate cancer diagnosis. *p < 0.05, **p < 0.001.... -
survival analysis
Mathematica notebook implementing the maximum likelihood method of our modified survival analysis. Allows parameter estimation and model comparison, as well as reproducing the... -
Analysis of curvature in fits of EOR model (2) with or without adjustment for...
All models have underlying rates adjusted for age (treated categorically) and gender. Unless otherwise stated all CI are profile-likelihood based. aunless otherwise stated all... -
Characteristics of the study population.
SD = standard deviation; BMI = body mass index; BFP = Body fat percentage measured with bioelectrical impedance [24]; WHR = waist-hip ratio; HGS = handgrip strength, the highest... -
Quality Assessment of Studies.
aConfounders of interest were lead-time bias and liver function for survival, liver function, and performance status for treatment eligibility, and liver function and body mass... -
Clinical characteristics of patients.
Mean±SD [25., 50. und 75. percentile in case of non-normal distribution] or number (%). ap<0.05;bp<0.01;cp<0.005;dp<0.001 – comparison between survivors and... -
Questionnaire 2.
Answers are expressed as percentage of all responses. Cut-off level to reach consensus: two-thirds (67%) of agreement of effective answers. -
Patient Characteristics.
Abbreviations: AML, acute myeloid leukemia; sAML, secondary AML; ALL, acute lymphoblastic leukemia; PMF, primary myelofibrosis; CLL: chronic lymphoblastic leukemia; SAA, severe... -
r37980778c78--92081724a456493864b362cd5709921f
Answers are expressed as percentage of all responses. Cut-off level to reach consensus: two-thirds (67%) of agreement of effective answers. -
Descriptive statistics.
Table 1. Descriptive statistics. (Notes: the R&D rec. and the R&D high variables are dummy variables equal to 1 if the associated expert's cost estimate... -
Demographic and clinical data.
Note. All figures are group means, with standard deviations in parentheses, unless otherwise stated. BDD = body dysmorphic disorder group; SZ = schizophrenia/schizoaffective... -
Patients characteristics.
Legend to Table 2 to 7B: The CTL epitopes that should be recognized according to the HLA alleles are defined using the HXB2 reference. The observed corresponding epitopes in the... -
Demographic and baseline characteristics of patients.
Demographic and baseline characteristics of patients.
